Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4597 Target Snapshot

Cyclin-dependent kinase 16 · SINGLE PROTEIN · Homo sapiens

704Compounds
174Assays
16Approved Drugs
402.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q00536. Use UniProt Q00536 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q00536 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cyclin-dependent kinase 16 as ChEMBL target CHEMBL4597, mapped to UniProt Q00536. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cyclin-dependent kinase 16
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4597
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q00536
Cyclin-dependent kinase 16
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cyclin-dependent kinase 16 is the right protein anchor across sources, using UniProt Q00536 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCyclin-dependent kinase 16
UniProt AccessionQ00536
Component TypeProtein
Sequence Length496 aa

Cyclin-dependent kinase 16

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cyclin-dependent kinase 16, mapped to UniProt Q00536. Sequence length is 496 aa.

Mapped IDQ00536
Review nameCyclin-dependent kinase 16
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

16
Approved
7
Phase III
17
Phase II
9
Phase I
Assay Mix

Activity Type Distribution

IC5013.0
EC501.0
KD388.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL384304 9.27 Kd 0.54 Clinical
CHEMBL445813 8.96 Kd 1.1 Clinical
CHEMBL3545083 8.52 Kd 3.0 Preclinical
CHEMBL296468 8.15 Kd 7.1 Preclinical
CHEMBL1082152 7.92 Kd 12.0 Preclinical
CHEMBL2028663 7.89 Kd 13.0 Approved
CHEMBL502835 7.68 Kd 21.0 Approved
CHEMBL191003 7.64 Kd 23.0 Preclinical
CHEMBL388978 7.62 Kd 24.0 Preclinical
CHEMBL603469 7.57 Kd 27.0 Clinical
Distribution

pChEMBL Value Distribution

15
5.0
26
5.5
21
6.0
12
6.5
4
7.0
10
7.5
3
8.0
2
8.5
1
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

ABEMACICLIB
CHEMBL3301610
Approved 2017
RUCAPARIB
CHEMBL1173055
Approved 2016
NINTEDANIB
CHEMBL502835
Approved 2014
DABRAFENIB
CHEMBL2028663
Approved 2013
SUNITINIB
CHEMBL535
Approved 2006
Assay Landscape

Assay Landscape

174
Total Assays
73
Tested Compounds
1
Assay Types
Binding — 174 assays, 73 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 102 45 6.3
cell-based format 26 0
subcellular format 25 28 6.4
assay format 21 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine